Multifunctional properties of RANKL/RANK in cell differentiation, proliferation and metastasis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multifunctional properties of RANKL/RANK in cell differentiation, proliferation and metastasis
Authors
Keywords
-
Journal
Future Oncology
Volume 9, Issue 11, Pages 1609-1622
Publisher
Future Medicine Ltd
Online
2013-10-24
DOI
10.2217/fon.13.115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential Expression of the RANKL/RANK/OPG System Is Associated with Bone Metastasis in Human Non-Small Cell Lung Cancer
- (2013) Xianbo Peng et al. PLoS One
- CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease
- (2012) D. J. Dairaghi et al. BLOOD
- Bone-Derived IGF Mediates Crosstalk between Bone and Breast Cancer Cells in Bony Metastases
- (2012) Toru Hiraga et al. CANCER RESEARCH
- RANK Induces Epithelial-Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis
- (2012) M. Palafox et al. CANCER RESEARCH
- CXCL10 Promotes Osteolytic Bone Metastasis by Enhancing Cancer Outgrowth and Osteoclastogenesis
- (2012) J.-H. Lee et al. CANCER RESEARCH
- Microenvironmental Regulation of Epithelial-Mesenchymal Transitions in Cancer
- (2012) D. Gao et al. CANCER RESEARCH
- Myeloid Progenitor Cells in the Premetastatic Lung Promote Metastases by Inducing Mesenchymal to Epithelial Transition
- (2012) D. Gao et al. CANCER RESEARCH
- EMT and Dissemination Precede Pancreatic Tumor Formation
- (2012) Andrew D. Rhim et al. CELL
- Salmonella Transforms Follicle-Associated Epithelial Cells into M Cells to Promote Intestinal Invasion
- (2012) Amin Tahoun et al. Cell Host & Microbe
- Receptor Activator of Nuclear Factor κB Ligand (RANKL) Protein Expression by B Lymphocytes Contributes to Ovariectomy-induced Bone Loss
- (2012) Melda Onal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Osteocyte RANKL: New insights into the control of bone remodeling
- (2012) Jinhu Xiong et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells
- (2012) Alexander G. Beristain et al. JOURNAL OF CELL SCIENCE
- Immunolocalization of sclerostin synthesized by osteocytes in relation to bone remodeling in the interradicular septa of ovariectomized rats
- (2012) Y. Guo et al. Microscopy
- c-Src Links a RANK/ v 3 Integrin Complex to the Osteoclast Cytoskeleton
- (2012) T. Izawa et al. MOLECULAR AND CELLULAR BIOLOGY
- The Ets transcription factor Spi-B is essential for the differentiation of intestinal microfold cells
- (2012) Takashi Kanaya et al. NATURE IMMUNOLOGY
- Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis
- (2012) Kazuhiro Maeda et al. NATURE MEDICINE
- Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
- (2012) David L. Lacey et al. NATURE REVIEWS DRUG DISCOVERY
- Characterization and Identification of Subpopulations of Mononuclear Preosteoclasts Induced by TNF-α in Combination with TGF-β in Rats
- (2012) Rei Matsubara et al. PLoS One
- Stage-specific functions of leukemia/lymphoma-related factor (LRF) in the transcriptional control of osteoclast development
- (2012) K. Tsuji-Takechi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Management of bone metastases in refractory prostate cancer – role of denosumab
- (2012) Channing Paller et al. Clinical Interventions in Aging
- Emerging Functions of RANKL in Lymphoid Tissues
- (2012) Christopher G. Mueller et al. Frontiers in Immunology
- Denosumab and the current status of bone-modifying drugs in breast cancer
- (2011) Brittany L. Lee et al. ACTA ONCOLOGICA
- The osteoclast and its unique cytoskeleton
- (2011) Steven L. Teitelbaum Annals of the New York Academy of Sciences
- The transcription factor FBI-1/OCZF/LRF is expressed in osteoclasts and regulates RANKL-induced osteoclast formation in vitro and in vivo
- (2011) Akiko Kukita et al. ARTHRITIS AND RHEUMATISM
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
- (2011) Myriam Labelle et al. CANCER CELL
- Targeting Regulatory T Cells in Cancer
- (2011) W. L. Byrne et al. CANCER RESEARCH
- The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells
- (2011) M. Shin et al. CARCINOGENESIS
- Molecular Pathways: Osteoclast-Dependent and Osteoclast-Independent Roles of the RANKL/RANK/OPG Pathway in Tumorigenesis and Metastasis
- (2011) W. C. Dougall CLINICAL CANCER RESEARCH
- Maspin, the Molecular Bridge between the Plasminogen Activator System and β1 Integrin That Facilitates Cell Adhesion
- (2011) Michael P. Endsley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The LRF transcription factor regulates mature B cell development and the germinal center response in mice
- (2011) Nagisa Sakurai et al. JOURNAL OF CLINICAL INVESTIGATION
- Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
- (2011) David H. Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- RANK Is Expressed in Metastatic Melanoma and Highly Upregulated on Melanoma-Initiating Cells
- (2011) Verena Kupas et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
- (2011) Matthew R Smith et al. LANCET
- Survival and Differentiation of Mammary Epithelial Cells in Mammary Gland Development Require Nuclear Retention of Id2 Due to RANK Signaling
- (2011) N.-S. Kim et al. MOLECULAR AND CELLULAR BIOLOGY
- From the ranks of mammary progesterone mediators, RANKL takes the spotlight
- (2011) Rodrigo Fernandez-Valdivia et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling
- (2011) Wei Tan et al. NATURE
- Matrix-embedded cells control osteoclast formation
- (2011) Jinhu Xiong et al. NATURE MEDICINE
- Evidence for osteocyte regulation of bone homeostasis through RANKL expression
- (2011) Tomoki Nakashima et al. NATURE MEDICINE
- Bone metastasis: mechanisms and therapeutic opportunities
- (2011) Larry J. Suva et al. Nature Reviews Endocrinology
- Receptor Activator of NF-kB (RANK) Expression in Primary Tumors Associates with Bone Metastasis Occurrence in Breast Cancer Patients
- (2011) Daniele Santini et al. PLoS One
- Receptor activator of NF- B (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit
- (2011) V. Duheron et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New Approaches to the Treatment of Osteoporosis
- (2010) Barbara C. Silva et al. Annual Review of Medicine
- Advances in the biology of bone metastasis: How the skeleton affects tumor behavior
- (2010) Julie A. Sterling et al. BONE
- Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)
- (2010) F. T. Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- Shedding of RANKL by Tumor-Associated MT1-MMP Activates Src-Dependent Prostate Cancer Cell Migration
- (2010) A. L. Sabbota et al. CANCER RESEARCH
- Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: Role in osteoclastogenesis and bone resorption
- (2010) Marc Baud’huin et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases
- (2010) Daniele Santini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
- (2010) Eva Gonzalez-Suarez et al. NATURE
- Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
- (2010) Daniel Schramek et al. NATURE
- Synthesis of artificial lymphoid tissue with immunological function
- (2010) Yuka Kobayashi et al. TRENDS IN IMMUNOLOGY
- Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
- (2009) Xiang H.-F. Zhang et al. CANCER CELL
- Glycosaminoglycans as Potential Regulators of Osteoprotegerin Therapeutic Activity in Osteosarcoma
- (2009) F. Lamoureux et al. CANCER RESEARCH
- LRF Is an Essential Downstream Target of GATA1 in Erythroid Development and Regulates BIM-Dependent Apoptosis
- (2009) Takahiro Maeda et al. DEVELOPMENTAL CELL
- A unique domain in RANK is required for Gab2 and PLCγ2 binding to establish osteoclastogenic signals
- (2009) Yuu Taguchi et al. GENES TO CELLS
- Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation
- (2009) Takako Negishi-Koga et al. IMMUNOLOGICAL REVIEWS
- Expansion of Antigen-Specific Regulatory T Cells with the Topical Vitamin D Analog Calcipotriol
- (2009) Mehran Ghoreishi et al. JOURNAL OF IMMUNOLOGY
- RANKL Is Necessary and Sufficient to Initiate Development of Antigen-Sampling M Cells in the Intestinal Epithelium
- (2009) K. A. Knoop et al. JOURNAL OF IMMUNOLOGY
- Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas
- (2009) Shuji Mikami et al. JOURNAL OF PATHOLOGY
- Osteoclasts are involved in the maintenance of dormant leukemic cells
- (2009) Asumi Yokota et al. LEUKEMIA RESEARCH
- CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model
- (2009) X. Ma et al. MOLECULAR CANCER THERAPEUTICS
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osteotropic cancers: From primary tumor to bone
- (2008) Jeroen T. Buijs et al. CANCER LETTERS
- Receptor activator of NF-κB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells
- (2008) Valerie A Odero-Marah et al. CELL RESEARCH
- Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy
- (2008) A. Lipton et al. CLINICAL CANCER RESEARCH
- The Cytokine RANKL Produced by Positively Selected Thymocytes Fosters Medullary Thymic Epithelial Cells that Express Autoimmune Regulator
- (2008) Yu Hikosaka et al. IMMUNITY
- The Tumor Necrosis Factor Family Receptors RANK and CD40 Cooperatively Establish the Thymic Medullary Microenvironment and Self-Tolerance
- (2008) Taishin Akiyama et al. IMMUNITY
- Heparin inhibits osteoclastic differentiation and function
- (2008) Wataru Ariyoshi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway
- (2008) Estelle Chamoux et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
- (2008) Georgiana K. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis
- (2008) R. E. Miller et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now